Alnylam Pharmaceuticals
ALNY
ALNY
248 hedge funds and large institutions have $4.11B invested in Alnylam Pharmaceuticals in 2016 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 109 increasing their positions, 62 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
11% less first-time investments, than exits
New positions opened: 33 | Existing positions closed: 37
11% less funds holding in top 10
Funds holding in top 10: 9 → 8 (-1)
Holders
248
Holding in Top 10
8
Calls
$68.7M
Puts
$33.7M
Top Buyers
| 1 | +$150M | |
| 2 | +$140M | |
| 3 | +$18.6M | |
| 4 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$17.9M |
| 5 |
Westfield Capital Management
Boston,
Massachusetts
|
+$15.4M |
Top Sellers
| 1 | -$75.7M | |
| 2 | -$58.7M | |
| 3 | -$49.7M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$45.9M |
| 5 |
Franklin Resources
San Mateo,
California
|
-$19.5M |